TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06331-8
PubMed Identifier: 35698158
Publication URI: http://europepmc.org/abstract/MED/35698158
Type: Journal Article/Review
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215